# Camden Property Trust: financial statements, quarterly

CPT · NYSE · CIK 906345 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cpt.md) · [Financials](/companies/cpt/financials.md) · [Filings](/companies/cpt/filings.md) · [Insiders](/companies/cpt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cpt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.1](/filings/0000906345-24-000041.md) | [1.1 d](/filings/0001628280-26-007697.md) | [1.3](/filings/0000906345-25-000023.md) | [2.6](/filings/0000906345-25-000034.md) | [1.7](/filings/0001628280-25-050524.md) | [1.5 d](/filings/0001628280-26-007697.md) | [2.5](/filings/0001628280-26-029188.md) | [2.6](/filings/0001628280-26-051327.md) | [2.6](/filings/0001628280-25-050524.md) | [5.3 d](/filings/0001628280-26-007697.md) | [2.1](/filings/0001628280-26-029188.md) | [3.1](/filings/0001628280-26-051327.md) |
| Interest expense | $m | [33.0](/filings/0000906345-24-000041.md) | [34.0 d](/filings/0001628280-26-007697.md) | [32.5](/filings/0000906345-25-000023.md) | [32.2](/filings/0000906345-25-000034.md) | [32.5](/filings/0001628280-25-050524.md) | [32.6 d](/filings/0001628280-26-007697.md) | [33.8](/filings/0001628280-26-029188.md) | [35.4](/filings/0001628280-26-051327.md) | [35.0](/filings/0001628280-25-050524.md) | [34.1 d](/filings/0001628280-26-007697.md) | [37.4](/filings/0001628280-26-029188.md) | [41.4](/filings/0001628280-26-051327.md) |
| Net income | $m | [48.0](/filings/0000906345-24-000041.md) | [222 d](/filings/0001628280-26-007697.md) | [83.9](/filings/0000906345-25-000023.md) | [42.9](/filings/0000906345-25-000034.md) | [(4.2)](/filings/0001628280-25-050524.md) | [40.7 d](/filings/0001628280-26-007697.md) | [38.8](/filings/0001628280-26-029188.md) | [80.7](/filings/0001628280-26-051327.md) | [109](/filings/0001628280-25-050524.md) | [156 d](/filings/0001628280-26-007697.md) | [42.4](/filings/0001628280-26-029188.md) | [18.8](/filings/0001628280-26-051327.md) |
| Diluted EPS | $ per share | [0.44](/filings/0000906345-24-000041.md) | not reported | [0.77](/filings/0000906345-25-000023.md) | [0.40](/filings/0000906345-25-000034.md) | [(0.04)](/filings/0001628280-25-050524.md) | not reported | [0.36](/filings/0001628280-26-029188.md) | [0.74](/filings/0001628280-26-051327.md) | [1.00](/filings/0001628280-25-050524.md) | not reported | [0.40](/filings/0001628280-26-029188.md) | [0.18](/filings/0001628280-26-051327.md) |
| Basic EPS | $ per share | [0.44](/filings/0000906345-24-000041.md) | not reported | [0.77](/filings/0000906345-25-000023.md) | [0.40](/filings/0000906345-25-000034.md) | [(0.04)](/filings/0001628280-25-050524.md) | not reported | [0.36](/filings/0001628280-26-029188.md) | [0.74](/filings/0001628280-26-051327.md) | [1.00](/filings/0001628280-25-050524.md) | not reported | [0.40](/filings/0001628280-26-029188.md) | [0.18](/filings/0001628280-26-051327.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [14.6](/filings/0000906345-24-000041.md) | [260](/filings/0001628280-26-007697.md) | [92.7](/filings/0000906345-25-000023.md) | [93.9](/filings/0000906345-25-000034.md) | [31.2](/filings/0001628280-25-050524.md) | [21.0](/filings/0001628280-26-007697.md) | [26.2](/filings/0001628280-26-029188.md) | [33.1](/filings/0001628280-26-051327.md) | [25.9](/filings/0001628280-25-050524.md) | [25.2](/filings/0001628280-26-051327.md) | [40.7](/filings/0001628280-26-029188.md) | [44.7](/filings/0001628280-26-051327.md) |
| Total assets | $m | [9,214](/filings/0000906345-23-000045.md) | [9,384](/filings/0000906345-25-000008.md) | [9,104](/filings/0000906345-24-000017.md) | [9,080](/filings/0000906345-24-000027.md) | [8,947](/filings/0000906345-24-000041.md) | [8,852](/filings/0001628280-26-007697.md) | [8,993](/filings/0000906345-25-000023.md) | [9,120](/filings/0000906345-25-000034.md) | [9,055](/filings/0001628280-25-050524.md) | [9,043](/filings/0001628280-26-051327.md) | [9,060](/filings/0001628280-26-029188.md) | [9,456](/filings/0001628280-26-051327.md) |
| Total liabilities | $m | [4,279](/filings/0000906345-23-000045.md) | [4,332](/filings/0000906345-25-000008.md) | [4,110](/filings/0000906345-24-000017.md) | [4,153](/filings/0000906345-24-000027.md) | [4,133](/filings/0000906345-24-000041.md) | [4,105](/filings/0001628280-26-007697.md) | [4,306](/filings/0000906345-25-000023.md) | [4,460](/filings/0000906345-25-000034.md) | [4,443](/filings/0001628280-25-050524.md) | [4,605](/filings/0001628280-26-051327.md) | [4,955](/filings/0001628280-26-029188.md) | [5,578](/filings/0001628280-26-051327.md) |
| Long-term debt | $m | [3,653](/filings/0000906345-23-000045.md) | [3,715](/filings/0000906345-24-000007.md) | [3,554](/filings/0000906345-24-000017.md) | [3,553](/filings/0000906345-24-000027.md) | [3,452](/filings/0000906345-24-000041.md) | [3,486](/filings/0000906345-25-000008.md) | [3,736](/filings/0000906345-25-000023.md) | [3,826](/filings/0000906345-25-000034.md) | [3,740](/filings/0001628280-25-050524.md) | [3,901](/filings/0001628280-26-007697.md) | [4,251](/filings/0001628280-26-029188.md) | [4,848](/filings/0001628280-26-051327.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | [600](/filings/0000906345-25-000023.md) | [600](/filings/0000906345-25-000034.md) | [600](/filings/0001628280-25-050524.md) | not reported | [600](/filings/0001628280-26-029188.md) | [600](/filings/0001628280-26-051327.md) |
| Shareholders' equity | $m | [4,864](/filings/0000906345-23-000045.md) | [4,981](/filings/0000906345-25-000008.md) | [4,922](/filings/0000906345-24-000017.md) | [4,855](/filings/0000906345-24-000027.md) | [4,743](/filings/0000906345-24-000041.md) | [4,675](/filings/0001628280-26-007697.md) | [4,615](/filings/0000906345-25-000023.md) | [4,587](/filings/0000906345-25-000034.md) | [4,536](/filings/0001628280-25-050524.md) | [4,363](/filings/0001628280-26-051327.md) | [4,029](/filings/0001628280-26-029188.md) | [3,802](/filings/0001628280-26-051327.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [236 d](/filings/0000906345-24-000041.md) | [192 d](/filings/0001628280-26-007697.md) | [136](/filings/0000906345-25-000023.md) | [225 d](/filings/0000906345-25-000034.md) | [262 d](/filings/0001628280-25-050524.md) | [152 d](/filings/0001628280-26-007697.md) | [148](/filings/0001628280-26-029188.md) | [231 d](/filings/0001628280-26-051327.md) | [251 d](/filings/0001628280-25-050524.md) | [197 d](/filings/0001628280-26-007697.md) | [148](/filings/0001628280-26-029188.md) | [212 d](/filings/0001628280-26-051327.md) |
| Dividends paid | $m | [110 d](/filings/0000906345-24-000041.md) | [110 d](/filings/0001628280-26-007697.md) | [110](/filings/0000906345-25-000023.md) | [114 d](/filings/0000906345-25-000034.md) | [114 d](/filings/0001628280-25-050524.md) | [114 d](/filings/0001628280-26-007697.md) | [114](/filings/0001628280-26-029188.md) | [116 d](/filings/0001628280-26-051327.md) | [116 d](/filings/0001628280-25-050524.md) | [115 d](/filings/0001628280-26-007697.md) | [115](/filings/0001628280-26-029188.md) | [112 d](/filings/0001628280-26-051327.md) |
| Share repurchases | $m | [0.0 d](/filings/0000906345-24-000041.md) | [0.0 d](/filings/0001628280-26-007697.md) | [45.7](/filings/0000906345-25-000023.md) | [4.3 d](/filings/0000906345-25-000034.md) | [0.0 d](/filings/0001628280-25-050524.md) | [0.0 d](/filings/0001628280-26-007697.md) | [0.0](/filings/0001628280-26-029188.md) | [0.0 d](/filings/0001628280-26-051327.md) | [50.0 d](/filings/0001628280-25-050524.md) | [221 d](/filings/0001628280-26-007697.md) | [263](/filings/0001628280-26-029188.md) | [170 d](/filings/0001628280-26-051327.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [109](/filings/0000906345-23-000045.md) | [109](/filings/0000906345-24-000017.md) | [109](/filings/0000906345-24-000027.md) | [109](/filings/0000906345-24-000041.md) | [109](/filings/0000906345-25-000023.md) | [108](/filings/0000906345-25-000034.md) | [108](/filings/0001628280-25-050524.md) | [109](/filings/0001628280-26-029188.md) | [109](/filings/0001628280-26-051327.md) | [109](/filings/0001628280-25-050524.md) | [105](/filings/0001628280-26-029188.md) | [102](/filings/0001628280-26-051327.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 100,539,350 at 2026-07-24, from the cover of the [10-Q filed 2026-07-31](/filings/0001628280-26-051327.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.